NewsBenzinga파라마운트, WBD 합병 장애물 해소 위해 캘리포니아주 법무장관과 협상 마무리 단계···뉴욕·코네티컷주 추가 양보 요구 속 15억 달러 투자 검토 파라마운트, WBD 합병 장애물 해소 위해 캘리포니아주 법무장관과 협상 마무리 단계···뉴욕·코네티컷주 추가 양보 요구 속 15억 달러 투자 검토 Benzinga 2026.09.21 09:22 (GMT+0) Open on Benzinga Other news ENSv2 Activation Proposal Would Halt New ENSv1 Registrations Reported Sunday, BridgeBio’s Encaleret Raises Bone Turnover, With 100% Of Phase 3 CALIBRATE Participants Reporting Improvement In At Least One ADH1 Symptom Versus 46% On Standard Of Care Reported Sunday, AbbVie’s SKYRIZI Shows Sustained Endoscopic Outcomes Through 144 Weeks In Crohn’s And 74.5% Fistula Resolution At Five Years, While RINVOQ Real-World Data Show Remission In Advanced Crohn’s Reported Sunday, Stellantis Previews Six Of Nine Concept Cars Debuting At Paris Motor Show October 12-18, Highlighting FaSTLAne 2030 Strategy Results Reported Sunday, BridgeBio Presents Acoramidis Data At HFSA 2026 Showing 18% Lower Composite Risk Versus Tafamidis In Real-World Study Of 2,684 ATTR-CM Patients And Mortality Rising After Cardiovascular Hospitalizations Hong Kong to list second spot Solana ETF on October 13
Reported Sunday, BridgeBio’s Encaleret Raises Bone Turnover, With 100% Of Phase 3 CALIBRATE Participants Reporting Improvement In At Least One ADH1 Symptom Versus 46% On Standard Of Care
Reported Sunday, AbbVie’s SKYRIZI Shows Sustained Endoscopic Outcomes Through 144 Weeks In Crohn’s And 74.5% Fistula Resolution At Five Years, While RINVOQ Real-World Data Show Remission In Advanced Crohn’s
Reported Sunday, Stellantis Previews Six Of Nine Concept Cars Debuting At Paris Motor Show October 12-18, Highlighting FaSTLAne 2030 Strategy Results
Reported Sunday, BridgeBio Presents Acoramidis Data At HFSA 2026 Showing 18% Lower Composite Risk Versus Tafamidis In Real-World Study Of 2,684 ATTR-CM Patients And Mortality Rising After Cardiovascular Hospitalizations
